Baylor Sammons Cancer Center is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Baylor Sammons Cancer Center has participated in 23 clinical trials with 1 currently active.
Therapeutic areas: Relapsed and/or Refractory Multiple Myeloma (RRMM), Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic.
Sponsors: Takeda, CureTech Ltd, Sumitomo Pharma America, Inc..
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Baylor Sammons Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Baylor Sammons Cancer Center has 23 clinical trials on record, with 1 currently active. Their work covers Relapsed and/or Refractory Multiple Myeloma (RRMM), Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic.
Yes — Baylor Sammons Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.